Adenocarcinoma of the Stomach
📧 Sign up to get email alerts when something new happens for Adenocarcinoma of the Stomach.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Perioperative FLOT vs Adjuvant XELOX for CA Stomach [Phase 3]
Phase 3 trial updating perioperative FLOT vs adjuvant XELOX for stomach cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: EGFR-targeted Therapy for Gastric Cancer [Phase 2]
Phase 2 trial update of an EGFR-targeted therapy in gastric cancer (adenocarcinoma of the stomach).
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma [Phase 2]
Phase 2 trial evaluating ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in HER2-positive gastroesophageal adenocarcinoma…
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: Camrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric Adenocarcinoma [Phase 2]
Phase 2 trial update evaluating camrelizumab in combination with apatinib for advanced gastric/GEJ adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2021-04-29Clinical Trial Update: Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction [Phase 1, Phase 2]
Feasibility study results for adjuvant S-1 therapy after R0 resection in stomach and esophagogastric junction adenocarcinoma completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer [Phase 2]
Phase 2 trial evaluating S-1 maintenance therapy in unresectable, locally advanced or metastatic gastric/GEJ adenocarcinoma has been complet…
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Avelumab + Paclitaxel/ Ramucirumab (RAP) as Second Line Treatment in Gastro-esophageal Adenocarcinoma [Phase 2]
Phase 2 trial evaluating avelumab plus paclitaxel or ramucirumab as second-line therapy for gastroesophageal junction adenocarcinoma and sto…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction [Phase 1]
This Phase 1 trial evaluates a multimodal approach using oxaliplatin, fluorouracil, and erlotinib with pre-surgical radiation, followed by a…
-
CLINICAL_TRIALS trial_result · 2017-06-19Clinical Trial Update: Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach [Phase 2]
A completed Phase II exploratory trial evaluating perioperative treatment for adenocarcinoma of the gastroesophageal junction or stomach.
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer [Phase 2]
A Phase 2 clinical trial evaluated chemotherapy with or without vismodegib in patients with advanced stomach or gastroesophageal junction ad…
-
CLINICAL_TRIALS trial_result · 2015-07-21Clinical Trial Update: Pharmacokinetic Study of Capecitabine After Total Gastrectomy for Stomach Adenocarcinoma [Phase 4]
This document provides a Phase 4 pharmacokinetic update for capecitabine in patients who underwent total gastrectomy for stomach adenocarcin…
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 clinical trial update of saracatinib for locally advanced or metastatic stomach/ gastroesophageal junction cancer; results posted af…
-
CLINICAL_TRIALS trial_result · 2009-04-28Clinical Trial Update: Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus [Phase 2]
Phase 2 trial evaluating doxorubicin, cisplatin, and 5-fluorouracil in patients with advanced adenocarcinoma of the stomach, gastroesophagea…